FDA 483 - New York Blood Center Enterprises - September 29, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of New York Blood Center, Inc. in Long Island City revealed significant deficiencies in their blood bank operations. Observations included failures to establish and follow adequate standard operating procedures for blood product irradiation and donor physical examinations, as well as issues with maintaining proper temperatures during Red Blood Cell shipments. Additionally, the firm lacked sufficient documentation for the validation of its electronic health history questionnaire and exhibited discrepancies in concurrent record-keeping for blood component processing.
ID · 89e4ed87-8aee-4226-bc00-c4c265fec5a4